Clinical trial
18F-Fluoroazomycin Arabinoside (18F-FAZA) in Lung Cancer
NCT02701699
Study timeline
Study start (actual)2014-12-01Date precision: month
Registry last updated2026-03-06
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Lung Cancerunresolved
Interventions
18-F-FAZABIOLOGICAL
Sponsors & collaborators
University Health Network, Torontolead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02701699 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.